TGM1 and thymoma: in terms of PFI, we observed a significant correlation between high expression of TGM1 and poor prognosis in patients with KIPAN, KIRC, ACC, STES, LIHC, Stomach adenocarcinoma (STAD), and BCLA and low expression of TGM1 was associated with poor prognosis in patients with GBMLGG and Thymoma (THYM) (Fig. 1C).